The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules

By de la Torre Beatriz G.   Albericio Fernando  

Molecules, Vol. 23, Iss. 3, 2018-02 ,pp. : 533-533

MDPI

Access to resources Recommend Favorite

Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry

By Wijesekara Isuru   Kim Se-Kwon  

Marine Drugs, Vol. 8, Iss. 4, 2010-03 ,pp. : 1080-1093

MDPI

Access to resources Recommend Favorite

Pharmacophore Generation from a Drug-like Core Molecule Surrounded by a Library Peptide via the 10BASE_d-T on Bacteriophage T7

By Tokunaga Yuuki   Azetsu Yuuki   Fukunaga Keisuke   Hatanaka Takaaki   Ito Yuji   Taki Masumi  

Molecules, Vol. 19, Iss. 2, 2014-02 ,pp. : 2481-2496

MDPI

Access to resources Recommend Favorite

Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin

By Subra Arun K.   Nissen Mark S.   Lewis Kevin M.   Muralidharan Ashwin K.   Sanchez Emiliano J.   Milting Hendrik   Kang ChulHee  

International Journal of Molecular Sciences, Vol. 13, Iss. 11, 2012-11 ,pp. : 14326-14343

MDPI

Access to resources Recommend Favorite

Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes

By Costa Valerio   Federico Antonio   Pollastro Carla   Ziviello Carmela   Cataldi Simona   Formisano Pietro   Ciccodicola Alfredo  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1008-1008

MDPI

Access to resources Recommend Favorite